Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adenofit-Forte is a multi-ingredient phytotherapeutic supplement developed by NutriMed Group, specifically formulated to support prostate health and manage symptoms of benign prostatic hyperplasia (BPH) and chronic prostatitis. The preparation contains a synergistic blend of Saw Palmetto (Serenoa repens) extract, Nettle (Urtica dioica) root extract, and Pumpkin seed extract, enriched with lycopene, zinc, and selenium. Its therapeutic action is primarily driven by the inhibition of 5-alpha-reductase, which prevents the conversion of testosterone into dihydrotestosterone (DHT), thereby slowing prostate tissue growth. Additionally, it exhibits anti-inflammatory properties by modulating the cyclooxygenase pathway and provides antioxidant protection to mitigate oxidative stress in the urogenital system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Adenofit-Forte.